References
- Case A, Deaton A. Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci U S A. 2015;112(49):15078–15083.
- Centers for Disease Control and Prevention/National Center for Health Statistics. National Vital Statistics System, Mortality File.; 2015. Available at: http://www.cdc.gov/nchs/data/health_policy/AADR_drug_poisoning_involving_OA_Heroin_US_2000-2014.pdf. Number and age-adjusted rates of drug poisoning deaths involving opioid analgesics and heroin: United States, 2000-2014.
- Rudd RA, Paulozzi LJ, Bauer MJ, et al. Increases in heroin overdose deaths—28 States, 2010 to 2012. MMWR Morb Mort Wkly Rep. 2014;63:849–854.
- Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend. 2013;131:263–270.
- Han B, Hedden SL, Lipari R, Copello EAP, Kroutil LA. Receipt of Services for Behavioral Health Problems: Results From the 2014 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015.
- Gordon AJ, Jenkins JA. The time is now: the role of pharmacotherapies in expanding treatment for opioid use disorder. Subst Abus. 2015;36:127–128.
- Oliva EM, Nevedal AL, Lewis ET, et al. Patient perspectives on an opioid overdose education and naloxone distribution program in the US Department of Veterans Affairs Subst Abus. 2016;37.
- Winstanley EL, Clark A, Feinberg J, Wilder C. Barriers to implementation of opioid overdose prevention programs in Ohio. Subst Abus. 2016;37.
- Ashrafioun L, Gamble S, Herrmann M, Baciewicz G. Evaluation of knowledge and confidence following opioid overdose prevention training: a comparison of types of training participants and naloxone administration methods. Subst Abus. 2016;37.
- Haug NA, Bielenberg J, Linder SH, Lembke A. Assessment of provider attitudes toward #Naloxone on Twitter. Subst Abus. 2016;37.
- Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162:276–286.
- Morasco B, Peters D, Krebs E, Hart K, Kovas A, Dobscha S. Predictors of urine drug testing for patients with chronic pain: results from a national cohort of US veterans. Subst Abus. 2016;37.
- McCauley JL, Leite RS, Melvin CL, Fillingim RB, Brady K. Dental opioid prescribing practices and risk mitigation strategy implementation: identification of potential targets for provider-level intervention. Subst Abus. 2016;37.
- Bauer SR, Hitchner L, Harrison H, Gerstenberger J, Steiger S. Predictors of higher risk chronic opioid prescriptions in an academic primary care setting. Subst Abus. 2016;37.
- Starrels J, Peyser D, Haughton L, et al. When HIV treatment goals conflict with guideline-based opioid prescribing: a qualitative study of HIV providers. Subst Abus. 2016;37.
- Stumbo SP, Yarborough BJH, Janoff SL, Yarborough MT, McCarty D, Green CA. A qualitative analysis of family involvement in prescribed opioid medication monitoring among individuals who have experienced opioid overdoses. Subst Abus. 2016;37.
- Broyles LM, Binswanger IA, Jenkins JA, et al. Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response. Subst Abus. 2014;35:217–221.